Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 7,314,000 | 6,042,000 | 6,535,000 | 4,999,000 | 3,120,138 |
| Cost of Goods | 1,063,000 | 987,000 | 925,000 | 813,000 | 858,021 |
| Gross Profit | 6,251,000 | 5,055,000 | 5,610,000 | 4,186,000 | 2,262,117 |
| Operating Expenses | 1,921,000 | 1,575,000 | 1,198,000 | 1,143,000 | 1,065,096 |
| Operating Income | 4,330,000 | 3,480,000 | 4,412,000 | 3,043,000 | 1,197,042 |
| Interest Expense | 130,000 | 104,000 | 102,000 | 76,000 | 73,256 |
| Other Income | 30,000 | -5,000 | -4,000 | -18,000 | -11,222 |
| Pre-tax Income | 4,230,000 | 3,371,000 | 4,306,000 | 2,949,000 | 1,112,564 |
| Income Tax | 768,000 | 647,000 | 656,000 | 726,000 | 326,108 |
| Net Income Continuous | 3,462,000 | 2,724,000 | 3,650,000 | 2,223,000 | 786,456 |
| Minority Interests | -25,000 | -7,000 | -6,000 | -4,000 | -5,147 |
| Net Income | $3,487,000 | $2,731,000 | $3,656,000 | $2,227,000 | $791,603 |
| EPS Basic Total Ops | 2.31 | 1.80 | 2.39 | 1.45 | 0.52 |
| EPS Basic Continuous Ops | 2.30 | 1.80 | 2.38 | 1.45 | 0.51 |
| EPS Diluted Total Ops | 2.15 | 1.67 | 2.20 | 1.33 | 0.45 |
| EPS Diluted Continuous Ops | 2.14 | 1.66 | 2.19 | 1.32 | 0.46 |
| EBITDA(a) | $4,605,000 | $3,748,000 | $4,678,000 | $3,284,000 | $1,325,297 |